The Limited Times

Now you can see non-English news...

Covid vaccines: the first injections of Novavax in France may be "at the beginning of February"

2022-01-06T19:19:53.644Z


This vaccine has the particularity of not using messenger RNA technology, unlike those from Pfizer and Moderna.


The first injections in France of the anti-Covid vaccine from Novavax, the fifth to have been approved in the European Union, could take place "at the

beginning of February

", the Ministry of Health said Thursday, January 6.

Read also Could the new Novavax vaccine convince the last recalcitrant?

This vaccine was approved on December 20 in the EU and its use in France is still subject to the opinion of the Haute Autorité de Santé (HAS).

This opinion is expected "

in the days to come

", according to the Ministry of Health.

According to the ministry, France is to receive “

3.2 million doses

” of this vaccine in the first quarter, and has asked for an option for “

3.2 million additional doses

” in the second quarter.

The first deliveries are expected " at the

end of January

" according to the ministry, but "

signals indicate that there could be delays

".

Subject to the approval of the HAS, "

we could start at the beginning of February

" to inject this vaccine in France, the same source continued.

A so -called "subunit

"

vaccine

This vaccine has the particularity of not using messenger RNA technology, unlike those of Pfizer and Moderna (the only two hegemonic today in France after the gradual abandonment of those of AstraZeneca and Janssen). Sold under the name Nuvaxovid, this vaccine manufactured by the American laboratory Novavax is a so

-

called "subunit" vaccine : it contains a component of the virus (and not the whole virus like the most classic vaccines), introduced into the body. to trigger an immune response.

It is on this technique that the vaccines against pertussis, meningococcal meningitis and hepatitis B are based. It could remove the reluctance of people who refuse to be vaccinated because the technology of mRNA is quite new.

"

May (this vaccine) be a solid encouragement to the unvaccinated or those who have not been recalled!"

“, Thus hoped the President of the European Commission, Ursula von der Leyen, when it was approved in the EU.

SEE ALSO

- Why is there no French vaccine against Covid-19? (01/23/21)

Source: lefigaro

All news articles on 2022-01-06

You may like

News/Politics 2024-02-15T06:00:59.458Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.